v3.26.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating expenses:    
Research and development $ 12,606,000 $ 28,476,000
General and administrative 13,969,000 13,550,000
Operating loss (26,575,000) (42,026,000)
Other income (expense), net:    
Interest expense (207,000) (1,316,000)
Interest income and other income (expense), net 520,000 1,499,000
Other income (expense), net 313,000 183,000
Provision for income taxes 0 0
Net loss $ (26,262,000) $ (41,843,000)
Net loss per share of common stock and pre-funded warrants, basic [1] $ (6.33) $ (19.5)
Net loss per share of common stock and pre-funded warrants, diluted [1] $ (6.33) $ (19.5)
Weighted-average shares used in computing basic net loss per share [1] 4,149,733 2,146,276
Weighted-average shares of common stock and pre-funded warrants outstanding, diluted [1] 4,149,733 2,146,276
[1]

(1) Results, including shares of common stock, have been adjusted to reflect the one-for-thirteen stock split effected in April 2025. See Note 1, Organization and Description of the Business, for details.